[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369825-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-369825-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","deciphering-pancreatobiliary-intraductal-oncocytic-papillary-neoplasms-integrative-analysis","Deciphering pancreatobiliary intraductal oncocytic papillary neoplasms - integrative analysis","","Reviewing intraductal oncocytic papillary neoplasm (IOPN) of the pancreas, this work synthesizes developments from 2015–2024 to clarify biological behavior and diagnostic traits. It focuses on immunohistochemical markers, molecular pathology, and pathogenic mechanisms derived from English-language literature. Findings highlight immunohistochemical candidates such as CD117 and HepPar-1, and define key gene fusions including ATP1B1::PRKACA, DNAJB1::PRKACA, and ATP1B1::PRKACB. It further characterizes an immune microenvironment with elevated PD-L1 and inflammatory infiltration.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deciphering-pancreatobiliary-intraductal-oncocytic-papillary-neoplasms-integrative-analysis/369825/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deciphering-pancreatobiliary-intraductal-oncocytic-papillary-neoplasms-integrative-analysis/369825.png","ImageObject",300,407,{"name":42,"@type":43},"Elsa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the integrative review on IOPN?","Question",{"text":63,"@type":64},"It reviews progress in characterizing pancreatic intraductal oncocytic papillary neoplasm, emphasizing immunohistochemical markers, molecular pathology, and mechanisms from 2015 to 2024.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which immunohistochemical markers and gene fusions are highlighted as important for IOPN?",{"text":68,"@type":64},"The review mentions CD117 and HepPar-1 among immunohistochemical candidates, and identifies ATP1B1::PRKACA, DNAJB1::PRKACA, and ATP1B1::PRKACB as molecular hallmarks.",{"name":70,"@type":61,"acceptedAnswer":71},"What immune microenvironment features are described for IOPN?",{"text":72,"@type":64},"IOPN is described as having elevated PD-L1 expression and substantial inflammatory cell infiltration, with immune cell composition changes in invasive components suggesting active immune surveillance.",{"name":74,"@type":61,"acceptedAnswer":75},"How do the molecular and immune findings relate to IOPN prognosis?",{"text":76,"@type":64},"Distinct genetic alterations and a unique immune microenvironment are presented as explanations for IOPN’s relatively favorable prognosis and for insights into immune regulation strategies in pancreatic cancer.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},369825,1791003162,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":119,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Qian et al. World Journal of Surgical Oncology (2025) 23:333  \n[https://doi.org/10.1186/s12957-025-03997-7](https://doi.org/10.1186/s12957-025-03997-7)  \nWorld Journal of Surgical Oncology  \nREVIEW Open Access  \nDeciphering pancreatobiliary intraductaloncocytic papillary neoplasms: integrative analysis of histomorphologic patterns, immunophenotypic markers, and emerging molecular biomarkers  \nYingxian Qian 1, Shengwei Mo 1 and Xiaoyan Chang 1*  \nAbstract  \nPurpose We reviewed recent advancements in the characterization of intraductal oncocytic papillary neoplasm (IOPN) of the pancreas, with a specific focus on developments in immunohistochemical markers, molecular pathology, and pathogenic mechanisms over the past ten years (2015–2024) . Through comprehensive analysis of current literature, we aimed to elucidate the evolving understanding of IOPN’s biological behavior and diagnostic features, while identifying potential areas for future research in this distinctive pancreatic neoplasm.  \nMethods English-language articles on IOPN were searched from Pubmed from the first report of IOPN of the pancreas in 2015 to 2024.  \nResults Significant advancements have been achieved in IOPN research. Molecular investigations discover several immunohistochemical markers which may facilitate the diagnosis of IOPN, including CD117, HepPar-1 . Significantly ATP1B1::PRKACA, DNAJB1::PRKACA and ATP1B1::PRKACB gene fusions are identified as molecular hallmarks of IOPN. These genetic alterations are believed to activate the cAMP-PKA signaling pathway, subsequently influencing mitochondrial substrates and contributing to the development of oncocytic features. The molecular signature not only enhances diagnostic specificity but also presents potential therapeutic targets. Furthermore, IOPN exhibits a unique tumor immune microenvironment characterized by elevated PD-L1 expression and substantial inflammatory cell infiltration. The invasive component showed decrease in CD4 + T cells and increase in CD8 + T cells and macrophages suggested the existence of an active immune surveillance, which partially explained why IOPN could have a better prognosis.  \nConclusions IOPN exhibits distinct genetic alterations and a unique immune microenvironment. These features not only elucidate the mechanism underlying the relatively favorable prognosis of IOPN and IOPN-derived pancreatic cancers but also offer novel insights into immune regulation strategies for pancreatic cancer.  \n*Correspondence: Xiaoyan Chang [changxy@pumch.cn](changxy@pumch.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nQian et al. World Journal of Surgical Oncology (2025) 23:333 Page 2 of 9  \nKeywords Intraductal oncocytic papillary neoplasm, IOPN, Molecular profile, Immunohistochemistry, Diagnosis, Prognosis  \nBackground  \nIntraductal oncocytic papillary neoplasm (IOPN) of the pancreas was first reported","cbCaikcS7d9x3TmR","https://ap.wps.com/l/cbCaikcS7d9x3TmR","pdf",2316694,"English","# Abstract\n# Purpose\n# Methods\n# Results\n## Clinical and diagnostic features\n## Molecular hallmarks and immune microenvironment\n# Conclusions\n# Keywords\n# Background\n# Methods and materials\n# Results\n## Clinical features","[{\"question\":\"What is the main focus of the integrative review on IOPN?\",\"answer\":\"It reviews progress in characterizing pancreatic intraductal oncocytic papillary neoplasm, emphasizing immunohistochemical markers, molecular pathology, and mechanisms from 2015 to 2024.\"},{\"question\":\"Which immunohistochemical markers and gene fusions are highlighted as important for IOPN?\",\"answer\":\"The review mentions CD117 and HepPar-1 among immunohistochemical candidates, and identifies ATP1B1::PRKACA, DNAJB1::PRKACA, and ATP1B1::PRKACB as molecular hallmarks.\"},{\"question\":\"What immune microenvironment features are described for IOPN?\",\"answer\":\"IOPN is described as having elevated PD-L1 expression and substantial inflammatory cell infiltration, with immune cell composition changes in invasive components suggesting active immune surveillance.\"},{\"question\":\"How do the molecular and immune findings relate to IOPN prognosis?\",\"answer\":\"Distinct genetic alterations and a unique immune microenvironment are presented as explanations for IOPN’s relatively favorable prognosis and for insights into immune regulation strategies in pancreatic cancer.\"}]","Deciphering pancreatobiliary intraductal oncocytic papillary neoplasms - integrative analysis | PDF",1790184765,23,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/311cc92580a54b87f065ee6b32182ef3.webp",983,1310,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c19e6271e06d29ad159e07a8663ec6b7.webp",982,1309,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e08f64fd185f51725e2cb1f04245cb2.webp",981,1308,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91da2b15fcb0509ac57ea3e09bdbe851.webp",980,1306]